减少儿童扁桃体切除术后阿片类药物处方:一项质量改进项目
该质量改进项目在儿童门诊手术中心分两个PDSA周期,通过医生教育和标准化处方方案(每患者7剂羟考酮),将扁桃体切除术后初始阿片类药物平均剂量从12.2剂降至6.9剂,降幅43%,且补药请求、7天急诊就诊和再入院率无变化。
要点
- 两轮PDSA干预使每患者初始羟考酮平均剂量从12.2剂降至9.2剂再至6.9剂(P<.001)。
- 补药请求率、7天急诊就诊率和再入院率在干预前后无变化。
- 定向医生教育和标准化处方方案可安全减少术后阿片类药物处方。
核心结论
- 定向医生教育和标准化扁桃体切除术后处方方案可安全减少术后阿片类药物处方。
- 仍需进一步PDSA周期以考虑更少的阿片类药物处方剂量。
研究设计与样本
- 质量改进项目,在儿童门诊手术中心分两个PDSA周期进行。
- 预干预阶段(2021年1月至6月)163例患者,PDSA 1阶段(2021年7月至12月)152例患者,PDSA 2阶段(2022年1月至6月)178例患者。
- PDSA 1为医生阿片类药物教育,PDSA 2为标准化处方方案(每患者7剂羟考酮)。
主要发现
- 每患者初始羟考酮平均剂量:预干预12.2剂 vs PDSA 1 9.2剂 vs PDSA 2 6.9剂(P<.001)。
- 补药请求率、7天急诊就诊率和再入院率在描述性分析和统计过程控制分析中均无变化。
- 两个PDSA周期内羟考酮处方剂量数减少43%。
关键数值与推荐
- 标准化处方方案为每患者7剂羟考酮。
- 评估指标包括初始阿片类药物处方剂量数、补药需求、7天急诊就诊和再入院。
临床怎么用
- 定向医生教育和标准化扁桃体切除术后处方方案可安全减少术后阿片类药物处方。
- 仍需进一步PDSA周期以考虑更少的阿片类药物处方剂量。
局限性
- 仍需进一步PDSA周期以考虑更少的阿片类药物处方剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Postoperative pain is the most common morbidity associated with tonsillectomy. Opioids are frequently used in multimodal posttonsillectomy analgesia regimens; however, concerns regarding respiratory depression, drug-drug interactions, and medication misuse necessitate responsible opioid stewardship among prescribing surgeons. It is unclear if intentionally reducing opioid prescription doses negatively affects the patient experience. METHODS: A quality improvement team reviewed all posttonsillectomy opioid prescriptions at a pediatric ambulatory surgery center between January and June 2021 (preintervention, 163 patients). Following this review, we performed an opioid education session for surgeons and studied opioid prescribing habits between July and December 2021 (Plan-Do-Study-Act [PDSA] 1, 152 patients). We then implemented a standardized prescription protocol of 7 doses of oxycodone per patient and again reviewed prescriptions between January and June 2022 (PDSA 2, 178 patients). The following measures were evaluated: initial number of opioid doses prescribed, need for refills, 7-day emergency department (ED) visits, and readmissions. RESULTS: Each intervention reduced the average number of initial oxycodone doses per patient (12.2 vs 9.2 vs 6.9 doses, P < .001). There were no changes in the rate of refill requests, 7-day ED visits, and readmissions, by descriptive or Statistical Process Control analyses. DISCUSSION: In 2 PDSA cycles, we achieved a 43% reduction in the number of doses of oxycodone prescribed following tonsillectomy. We did not observe any increased rates in balancing measures, which are surrogates for unintentional effects of PDSA changes, including refills, ED presentations, and readmission rates. IMPLICATIONS FOR PRACTICE: Directed provider education and standardized posttonsillectomy prescription protocols can safely decrease postoperative opioid prescribing. Further PDSA cycles are required to consider even fewer opioid prescription doses.
引用
- Amin SN, Thompson T, Wang X, et al. Reducing Pediatric Posttonsillectomy Opioid Prescribing: A Quality Improvement Initiative. Otolaryngol Head Neck Surg. 2023. PMID: 37747042. doi:10.1002/ohn.534
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。